Jazz Pharmaceuticals PLC (JAZZ) — Financial Flexibility Index
Jazz Pharmaceuticals PLC (JAZZ) has a Financial Flexibility Index of 0.06x as of March 2026. Free cash flow of $427.90 Million (operating CF $408.20 Million minus capex $19.70 Million) represents 0% of total liabilities ($7.33 Billion). Also explore net asset momentum of Jazz Pharmaceuticals PLC to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jazz Pharmaceuticals PLC Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Jazz Pharmaceuticals PLC across 21 annual periods. Check asset allocation strategy of Jazz Pharmaceuticals PLC to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Jazz Pharmaceuticals PLC (2005–2025)
Year-by-year free cash flow to debt coverage for Jazz Pharmaceuticals PLC. For the full company profile including market capitalisation, see market cap of Jazz Pharmaceuticals PLC.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $1.41 Billion | $1.36 Billion | $7.34 Billion | ▲ +5.7% |
| 2024 | 0.18x | $1.44 Billion | $1.40 Billion | $7.92 Billion | ▲ +25.1% |
| 2023 | 0.15x | $1.12 Billion | $1.09 Billion | $7.66 Billion | ▼ -36.2% |
| 2022 | 0.23x | $1.77 Billion | $1.27 Billion | $7.75 Billion | ▲ +131.0% |
| 2021 | 0.10x | $824.04 Million | $778.51 Million | $8.33 Billion | ▼ -77.8% |
| 2020 | 0.44x | $1.28 Billion | $899.65 Million | $2.88 Billion | ▲ +12.6% |
| 2019 | 0.39x | $958.74 Million | $776.40 Million | $2.43 Billion | ▲ +3.8% |
| 2018 | 0.38x | $930.37 Million | $798.90 Million | $2.45 Billion | ▲ +13.6% |
| 2017 | 0.33x | $807.04 Million | $693.09 Million | $2.41 Billion | ▲ +26.7% |
| 2016 | 0.26x | $772.12 Million | $590.54 Million | $2.92 Billion | ▼ -18.1% |
| 2015 | 0.32x | $567.90 Million | $531.94 Million | $1.76 Billion | ▼ -1.6% |
| 2014 | 0.33x | $644.74 Million | $405.76 Million | $1.97 Billion | ▲ +4.7% |
| 2013 | 0.31x | $294.89 Million | $283.62 Million | $942.69 Million | ▼ -2.9% |
| 2012 | 0.32x | $272.23 Million | $249.75 Million | $845.20 Million | ▼ -87.6% |
| 2011 | 2.59x | $157.38 Million | $151.60 Million | $60.78 Million | ▲ +328.2% |
| 2010 | 0.60x | $63.60 Million | $58.87 Million | $105.18 Million | ▲ +1209.2% |
| 2009 | -0.05x | $-9.82 Million | $-15.88 Million | $180.23 Million | ▲ +88.7% |
| 2008 | -0.48x | $-101.49 Million | $-130.23 Million | $210.38 Million | ▲ +5.6% |
| 2007 | -0.51x | $-77.94 Million | $-81.09 Million | $152.56 Million | ▼ -258.7% |
| 2006 | -0.14x | $-55.67 Million | $-57.35 Million | $390.87 Million | ▲ +20.6% |
| 2005 | -0.18x | $-50.75 Million | $-52.16 Million | $283.03 Million | — |